3 terminated, 1 recruiting, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Cancer of Ovary: new trials by email Literature Review of Cancer of Ovary trials Research Report on Cancer of Ovary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy Promitil - Cancer of Ovary, Pancreatic Ductal Adenocarcinoma | Phase 2 | Terminated | Lipomedix Pharmaceuticals Inc. | 19 | 2024-06-13 | 2026-01-09 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors MEDI4736 - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Terminated | Washington University School of Medicine | 4 | 2016-09-12 | 2018-11-06 |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM + Celecoxib + DC Vaccine - Cancer of Ovary, Cancer of the Ovary | Phase 1 / Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2015-09-04 | 2026-07-08 | |
| Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Fenretinide/LXS + Ketoconazole - Ovarian Cancer, Cancer of Ovary | Phase 1 / Phase 2 | Terminated | South Plains Oncology Consortium | 12 | 2012-02-01 | 2020-08-27 |
Ovarian Neoplasms (5) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1)
Adnexal Diseases (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Gonadal Disorders (5) · Neoplasms (5) · Neoplasms by Site (5) · Ovarian Diseases (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Breast Diseases (2)
Celecoxib (1) · Cisplatin (1) · Creatine Kinase, MM Form (1) · Fenretinide (1) · Ketoconazole (1) · durvalumab (1)
Lipomedix Pharmaceuticals Inc. (1) · Roswell Park Cancer Institute (1) · South Plains Oncology Consortium (1) · University of California, Davis (1) · Washington University School of Medicine (1)
United States (4) · Israel (1)
Amichai Meirovitz, MD (1) · Barry J Maurer, MD, PhD (1) · Eve Rodler, MD (1) · Jayanthi Lea, MD (1) · Nirit Yarom, MD (1) · Ofer Purim, MD (1) · Ora Rosengarten, MD (1) · Ramaswamy Govindan, M.D. (1) · Ravit Geva, MD (1) · Robert P Edwards, MD (1) · Ruth Peretz, MD (1) · Tali Levy, MD (1)
P01CA132714 (1)